Novartis India announced Financial Results Q1 2024-25

The comprehensive analytics outlining the performance and outlook of Novartis India Limited.‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Novartis India Limited.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 1.87 %. However, it did see a marginal increase of 13.7 % from the previous quarter. Expenses decreased slightly by -2.33 % quarter-on-quarter, aligning with the annual decline of -6.75 %. Operating profit, while up 38.34 % compared to last year, faced a quarter-on-quarter increase of 113.74 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.84 %, but an expansion of 12.15 % sequentially. Other income fell by -0.1 % compared to the last quarter, despite an annual decline of -16.52 %. Interest expenses dropped significantly by -6.25 % from the previous quarter, yet the year-over-year decrease remains at a moderate -67.39 %. Depreciation costs climbed by 292.86 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -64.74 %. Profit before tax grew annually by 21.25 % but saw an increase from the preceding quarter by 57.85 %.
Tax expenses as a percentage of profits decreased slightly by -3.46 % compared to last year, with a more notable quarter-on-quarter decrease of -7.6 %. Net profit rose by 27 % year-on-year but experienced a 75.27 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 26.92 % but a quarterly rise of 75.13 %. In summary, Novartis India Limited.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Novartis India Limited.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 1.87 % year-on-year growth, however, there was a minor increase of 13.7 % from the previous quarter. Expenses decreased by -6.75 % compared to the previous year, with a decrease of -2.33 % quarter-on-quarter. Operating Profit surged by 38.34 % annually, and saw a 113.74 % increase from the last quarter.
Net Profit showed yearly increase of 27 %, and experienced a 75.27 % increase from the previous quarter. Earnings Per Share (EPS) rose by 26.92 % annually, however rose by 75.13 % compared to the last quarter. In essence, while Novartis India Limited. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.